In Vitro and in Vivo Activity of SKI-606, a Novel SRC-Abl Inhibitor, Against Imatinib-Resistant BCR-Abl+ Neoplastic Cells
Cancer Research - United States
doi 10.1158/0008-5472.can-06-1199
Full Text
Open PDFAbstract
Available in full text
Date
November 17, 2006
Authors
Publisher
American Association for Cancer Research (AACR)